LXRX
Lexicon Pharmaceuticals Inc
1.80$
+0.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +207.6% | +2,013.5% | -88.5% | +21.7% | +44.1% | +22.6% | -3.8% | -31.2% | -35.5% | -66.9% | -54.1% | -62.3% | -41.1% | +104.0% | +928.5% | +468.9% | -35.9% | +8.4% | -30.0% | +409.5% | -92.5% | -98.8% | -53.4% | +766.2% | +2,481.5% | +60.2% | |
| – | – | – | +28.3% | +7.1% | +3.3% | +3.1% | +16.7% | -0.9% | +4.4% | -21.9% | -3.0% | +13.0% | -20.2% | +8.6% | -0.4% | +6.6% | +72.3% | -98.8% | +31.2% | +29.7% | -40.3% | +2,753.6% | -4.6% | +12.3% | -99.0% | -55.5% | |
| – | +154.9% | +1,689.1% | -88.5% | +21.7% | +44.1% | +22.6% | -3.8% | -31.2% | -35.5% | -66.9% | -54.1% | -62.3% | -4,507.0% | – | – | – | -331.5% | – | -31.3% | +425.1% | -93.1% | -348.1% | – | – | – | +62.6% | |
| – | +116.8% | +68.6% | +40.3% | +9.8% | +10.2% | +3.4% | +14.0% | -2.2% | +4.1% | -25.2% | -7.2% | +21.9% | -10.1% | +8.6% | -0.4% | +6.6% | +87.2% | -12.0% | -36.1% | -8.3% | +67.1% | -64.2% | -4.1% | +11.5% | +43.5% | -27.7% | |
| – | – | +14.1% | +11.4% | 0.0% | -19.9% | -2.3% | +17.4% | -2.8% | -2.2% | -4.3% | +16.2% | -23.1% | -1.8% | +0.5% | +13.4% | +22.8% | +80.6% | +53.8% | -3.7% | -10.9% | -99.9% | +68,377.7% | +48.7% | +103.2% | +46.5% | -73.9% | |
| – | +169.5% | +564.5% | -71.9% | +7.5% | +3.6% | +2.4% | +14.5% | -2.3% | +3.0% | -21.9% | 0.0% | +15.2% | -14.1% | +7.2% | +1.8% | +9.5% | +85.8% | +0.8% | -26.5% | +8.2% | -60.6% | -53.7% | +49.6% | +135.6% | +99.7% | -56.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -9,443.0% | – | – | – | -133.8% | – | – | – | – | – | |
| – | – | -25.6% | -97.8% | +4,542.9% | +718.5% | +23.3% | -0.8% | -14.8% | -2.9% | +10.2% | -8.3% | -7.0% | -16.4% | -6.8% | +14.3% | +198.4% | -2.3% | +6.3% | +197.5% | -0.5% | -29.7% | -94.5% | +246.6% | +371.3% | +18.9% | -46.5% | |
| – | – | – | – | – | – | – | +38.9% | -230.9% | – | – | – | – | – | – | – | – | – | – | – | – | -147.2% | – | – | – | – | – | |
| – | – | – | – | – | -117.6% | – | -200.0% | – | – | – | – | – | – | – | – | – | -24.8% | -380.7% | – | -271.4% | – | -95.6% | +132.2% | -67.4% | -52,003.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -145.0% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -1,173.6% | – | – | – | -127.7% | – | – | – | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.